Factors associated with relapse after emergency department treatment for acute XXXX .

@entity1 @entity748 @entity2544 @entity565 @entity134 @entity2613 @entity288
STUDY OBJECTIVE: The rate of relapse after emergency department treatment for acute @entity565 is high. Most studies on this subject were performed before the recent recommendations for routine use of @entity288 and followed the @entity1 for 10 or fewer days. We sought to evaluate relapse following @entity2613 treatment for acute @entity565 over a longer period, focusing particularly on the relationship between @entity134 use and outpatient follow-up visits. DESIGN: A prospective study in which we followed @entity1 for 21 days after discharge to determine their relapse rate (unscheduled return for @entity565 treatment) and compliance with scheduled outpatient appointments. SETTING: University-affiliated county hospital @entity2613 . @entity1 : One hundred four adult @entity748 @entity1 discharged from our @entity2613 after treatment under a standardized protocol. RESULTS: Follow-up was performed for 91 @entity1 (88%). There was no difference in the posttreatment forced expiratory volume at 1 second between those who relapsed (55.2%) and those who did not (57.8%; NS). Twenty-three @entity1 (25.3%) relapsed within 3 weeks of discharge. Ninety-one percent of relapses occurred before the @entity1 saw their primary care physician. Those who relapsed had a history of previous @entity2613 visits and hospitalizations. There was no difference in @entity2544 levels or history of cigarette use. @entity1 who relapsed within 3 days had higher eosinophil counts. CONCLUSION: Even with routine use of oral @entity288 , a high percentage of @entity1 relapse after @entity2613 treatment for acute @entity565 . @entity1 who relapse have a greater number of recent @entity2613 visits and so should be targeted for more aggressive management of their @entity565 .
